Agios Pharmaceuticals, Inc.AGIONASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-811.58%
Near historical average
Percentile
P21
Within normal range
Streak
3 yr
Consecutive growthContracting
Average
-777.35%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -811.58% | +29.5% |
| 2024 | -1150.98% | +19.8% |
| 2023 | -1434.83% | +46.3% |
| 2022 | -2671.93% | - |
| 2021 | 0.00% | - |
| 2020 | 0.00% | +100.0% |
| 2019 | -334.87% | +6.7% |
| 2018 | -359.01% | +50.9% |
| 2017 | -730.89% | -161.6% |
| 2016 | -279.40% | - |